Designed for Iovance Biotherapeutics, this 137,000 square foot Class A was developed to meet the company’s functional requirements while offering adaptability for future expansion. Iovance Biotherapeutic, a biopharmaceutical company, manufactures its lead product at the facility: an autologous, ready-to-infuse cell therapy that has demonstrated distinctive efficacy in the treatment of metastatic melanoma. The facility includes aseptic cell therapy manufacturing, analytical labs, training and process development rooms, and general office functions.